Health Care: Drugs

Aegerion Pharmaceuticals Inc (AEGR: NASDAQ)

$22 n/a | n/a%
12/26/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 22.00
52 Week High 74.58
52 Week Low 19.10
Avg. Daily Vol. (Mil) 1.24
Beta (3 year) -0.28
Share Related Items
Mkt Cap (Mil) 625.59
Shares Out (Mil) 28.44
Float (Mil) 18.77
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 11.90
Current Ratio 12.40
LT Debt/ Equity 1.31
Total Debt / Equity 1.33
Valuation Ratios
Price Earnings n.a.
Price/Sales 4.77
Price/Book 3.87
Price/Cash Flow -15.50
Per Share Data
Earnings -1.54
Sales 4.61
Book Value 5.68
Cash Flow -1.42
Business Summary
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company currently operates in one business segment focusing on the development and commercialization of its product, lomitapide.
General Information
101 Main Street, Suite 1850
Cambridge, MA 02142
www.aegerion.com
Industry : Drugs
Sector: Health Care
Employees: 268
CEO: Mr. Marc D. Beer
Short Interest
Current Month (Mil) 7.27
Previous Month (Mil) 7.21
Short Interest Ratio (Days) 11.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -11.10
Return on Investments -12.10
Profitability
Gross Margin 93.70
EBIT Margin -31.10
Profit Margin -34.40

Portfolios with AEGR

Latest AEGR Headlines from TheStreet

More Financial News for AEGR

Press Releases for AEGR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter